Bloomberg BNA’s Corporate Law & Accountability Report is available on the Corporate Law Resource Center. This news service keeps corporate practitioners informed of legal developments of...
By Michael Greene
Jan. 19 — The Delaware Chancery Court Jan. 16 declined to enter a proposed order to close a class action lawsuit because the parties had not given adequate notice of a stipulated “mootness fee” to the putative class.
“Although it is true that the Court is not being asked to take any action with respect to the Fee Stipulation, I conclude that, under this Court’s precedents, notice of the Fee Stipulation nevertheless should be given to the putative class of  stockholders before I may enter an order closing this case,” Chancellor Andre G. Bouchard opined.
After a stock-for-stock merger between Zalicus Inc. and Epirus Biopharmaceuticals Inc. closed, the plaintiffs contended that supplemental disclosures by Zalicus had mooted their breach of fiduciary duty claims. Subsequently, Zalicus agreed to pay the plaintiffs' counsel a “mootness fee” in the amount of $400,000, and the parties requested that the court close the case.
Chancellor Bouchard noted that in a recent Delaware decision—In re Astex Pharmaceuticals Inc. Shareholders Litigation—the chancery court declined to enter a proposed closure order because the putative class was not afforded notice of a stipulated mootness fee.
The plaintiffs attempted to distinguish Astex on the grounds that no class had been certified in this case.
However, Chancellor Bourchard opined that the existence of a certification order was irrelevant to the court's ruling in Astex.
“To my mind, the rationale underlying Astex, which is equally applicable here, is that notice is appropriate because it provides the information necessary for an interested person to object to the use of corporate funds, such as by ‘challeng[ing] the fee payment as waste in a separate litigation,' if the circumstances warrant,” he wrote.
To contact the reporter on this story: Michael Greene in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Ryan Tuck at email@example.com
The opinion is available at http://www.bloomberglaw.com/public/document/In_re_Zalicus_Inc_Stockholders_Litig_No_9602CB_2015_BL_10616_Del_.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)